Creative Planning Increases Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Creative Planning increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 32.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,011 shares of the company’s stock after buying an additional 2,460 shares during the quarter. Creative Planning’s holdings in Prestige Consumer Healthcare were worth $722,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PBH. Ariel Investments LLC grew its stake in Prestige Consumer Healthcare by 10.7% during the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after buying an additional 274,212 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in Prestige Consumer Healthcare by 26.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after purchasing an additional 272,773 shares during the last quarter. Victory Capital Management Inc. grew its stake in Prestige Consumer Healthcare by 9.0% during the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after purchasing an additional 171,357 shares during the last quarter. F M Investments LLC purchased a new stake in Prestige Consumer Healthcare during the 2nd quarter valued at about $11,162,000. Finally, Millennium Management LLC grew its stake in Prestige Consumer Healthcare by 565.1% during the 2nd quarter. Millennium Management LLC now owns 101,218 shares of the company’s stock valued at $6,969,000 after purchasing an additional 86,000 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

NYSE:PBH opened at $74.05 on Monday. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The firm has a market cap of $3.67 billion, a price-to-earnings ratio of 18.11, a price-to-earnings-growth ratio of 2.08 and a beta of 0.47. The company has a 50 day moving average price of $72.17 and a 200-day moving average price of $69.58. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.04. The firm had revenue of $267.10 million during the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business’s quarterly revenue was down 4.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.06 EPS. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have weighed in on PBH shares. DA Davidson boosted their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Jefferies Financial Group reiterated a “hold” rating and set a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $94.20.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.